Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview

Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication.

The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·        The US

·        Europe

·        New Zealand

·        China

·        South Korea

Key Regulatory Paths ·        510(k)

·        CE-IVD

·        TGA

·        NMPA

·        MDITAC

Leading Companies ·        1Drop Diagnostics

·        Bio-AMD Inc

·        BiOracle Ltd (Inactive)

·        Coris BioConcept

·        Cue Health Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Cardiac Markers Rapid Tests and POC Pipeline Market Segmentation by Territories

A few of the key territories for the cardiac markers rapid tests and POC pipeline market are the US, Europe, New Zealand, China, and South Korea. As of February 2024, the US accounted for the highest number of pipeline products.

Cardiac Markers Rapid Tests and POC Pipeline Market Analysis by Territories, 2024 (%)

Cardiac Markers Rapid Tests and POC Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Cardiac Markers Rapid Tests and POC Pipeline Market

Download a Free Report Sample

Cardiac Markers Rapid Tests and POC Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the cardiac markers rapid tests and POC pipeline products market are 510(k), CE-IVD, TGA, NMPA, and MDITAC. As of February 2024, 510(k) was the most followed pathway for pipeline products in the market.

Cardiac Markers Rapid Tests and POC Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Cardiac Markers Rapid Tests and POC Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Cardiac Markers Rapid Tests and POC Pipeline Market

Download a Free Report Sample

Cardiac Markers Rapid Tests and POC Pipeline Market – Competitive Landscape

A few of the key companies associated with the cardiac markers rapid tests and POC pipeline market are 1Drop Diagnostics, Bio-AMD Inc., BiOracle Ltd (Inactive), Coris BioConcept, and Cue Health Inc., among others.

Bio-AMD Inc: Bio-AMD is headquartered in Daresbury, the UK. It is a medical diagnostic company that develops point of care (POC) medical diagnostic device business and offers bio-alternative medical devices. Bio-AMD offers a magnetic immunoassay detection system (MIDS) and multiple application diagnostic technology. It serves customers through distributors across the US.

Coris BioConcept (Coris): Coris is headquartered in Namur City, Namur, Belgium. It is a medical device company that develops, manufactures, and markets rapid diagnostic tests. The company develops antigen detection tests for gastric, enteric, and respiratory diseases as well as test kits for veterinary and molecular fields. Coris offers custom test development and contract manufacturing services. The company conducts research and development on molecular biology and immuno-assays developments.

Cardiac Markers Rapid Tests and POC Pipeline Market Analysis by Companies, 2024

Cardiac Markers Rapid Tests and POC Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Cardiac Markers Rapid Tests and POC Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Cardiac Markers Rapid Tests and POC Pipeline Market Territories Outlook

  • The US
  • Europe
  • New Zealand
  • China
  • South Korea

Cardiac Markers Rapid Tests and POC Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE-IVD
  • TGA
  • NMPA
  • MDITAC

Scope

This report provides:

  • Extensive coverage of the Cardiac Markers Rapid Tests and POC under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Cardiac Markers Rapid Tests and POC and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Cardiac Markers Rapid Tests and POC under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

1Drop Diagnostics
Bio-AMD Inc
BiOracle Ltd (Inactive)
Coris BioConcept
Cue Health Inc
Diazyme Laboratories Inc
Duke University
Dynasil Corporation of America
Eachy Biopharmaceuticals Ltd
Maxim Biomedical Inc
MiCo BioMed Co Ltd
MyMD Pharmaceuticals Inc
Nanomix Inc
Nanospot.ai Inc
Novartis AG
Ohmx Corp
Thermo Fisher Scientific Inc
ThreeFold Sensors (Inactive)
True Diagnostics Inc
Upstream Medical Technologies Ltd

Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Cardiac Markers Rapid Tests & POC Overview 8

3 Products under Development 9

3.1 Cardiac Markers Rapid Tests & POC – Pipeline Products by Stage of Development 9

3.2 Cardiac Markers Rapid Tests & POC – Pipeline Products by Territory 10

3.3 Cardiac Markers Rapid Tests & POC – Pipeline Products by Regulatory Path 11

3.4 Cardiac Markers Rapid Tests & POC – Pipeline Products by Estimated Approval Date 12

4 Cardiac Markers Rapid Tests & POC – Pipeline Products under Development by Companies 13

4.1 Cardiac Markers Rapid Tests & POC Companies – Pipeline Products by Stage of Development 13

4.2 Cardiac Markers Rapid Tests & POC – Pipeline Products by Stage of Development 14

5 Cardiac Markers Rapid Tests & POC Companies and Product Overview 15

5.1 1Drop Diagnostics Company Overview 15

5.1.1 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 Bio-AMD Inc Company Overview 16

5.2.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 BiOracle Ltd (Inactive) Company Overview 17

5.3.1 BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 Coris BioConcept Company Overview 18

5.4.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 Cue Health Inc Company Overview 19

5.5.1 Cue Health Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.6 Diazyme Laboratories Inc Company Overview 20

5.6.1 Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.7 Duke University Company Overview 21

5.7.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 21

5.8 Dynasil Corporation of America Company Overview 22

5.8.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview 22

5.9 Eachy Biopharmaceuticals Ltd Company Overview 23

5.9.1 Eachy Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.10 Maxim Biomedical Inc Company Overview 25

5.10.1 Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.11 MiCo BioMed Co Ltd Company Overview 26

5.11.1 MiCo BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

5.12 MyMD Pharmaceuticals Inc Company Overview 27

5.12.1 MyMD Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.13 Nanomix Inc Company Overview 28

5.13.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.14 Nanospot.ai Inc Company Overview 29

5.14.1 Nanospot.ai Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.15 Novartis AG Company Overview 30

5.15.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 30

5.16 Ohmx Corp Company Overview 31

5.16.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 31

5.17 Thermo Fisher Scientific Inc Company Overview 32

5.17.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.18 ThreeFold Sensors (Inactive) Company Overview 33

5.18.1 ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

5.19 True Diagnostics Inc Company Overview 34

5.19.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.20 Upstream Medical Technologies Ltd Company Overview 35

5.20.1 Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 35

6 Cardiac Markers Rapid Tests & POC- Recent Developments 38

6.1 Dec 18, 2023: Trinity Biotech Announces Management Changes 38

6.2 Oct 20, 2023: Lumiradx Partners With Astrazeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub 38

6.3 Jul 06, 2023: Trinity Biotech Announces Q1 2023 Financial Results 39

6.4 Jun 27, 2023: bioMErieux’s Executive Committee evolves: Jennifer Zinn appointed Executive Vice President of Clinical Operations 43

6.5 Mar 08, 2023: bioMerieux Announces 2022 Financial Results for the year ending December 31, 2022 43

7 Appendix 45

7.1 Methodology 45

7.2 About GlobalData 48

7.3 Contact Us 48

7.4 Disclaimer 48

Table

Cardiac Markers Rapid Tests & POC – Pipeline Products by Stage of Development 9

Cardiac Markers Rapid Tests & POC – Pipeline Products by Territory 10

Cardiac Markers Rapid Tests & POC – Pipeline Products by Regulatory Path 11

Cardiac Markers Rapid Tests & POC – Pipeline Products by Estimated Approval Date 12

Cardiac Markers Rapid Tests & POC Companies – Pipeline Products by Stage of Development 13

Cardiac Markers Rapid Tests & POC – Pipeline Products by Stage of Development 14

1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 15

One Drop Diagnostic Device – Cardiovascular Disease – Product Status 15

One Drop Diagnostic Device – Cardiovascular Disease – Product Description 15

Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Digital Strip Reader – Cardiac Marker Test – Product Status 16

Digital Strip Reader – Cardiac Marker Test – Product Description 16

BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 17

biO1042 Test – Product Status 17

biO1042 Test – Product Description 17

Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 18

Microfluidic Chip – Product Status 18

Microfluidic Chip – Product Description 18

Cue Health Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Inflammation Test Kit – Product Status 19

Inflammation Test Kit – Product Description 19

Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 20

ProADM Point-of-Care – Product Status 20

ProADM Point-of-Care – Product Description 20

Duke University Pipeline Products & Ongoing Clinical Trials Overview 21

Multianalyte 2-D Diffusion Point-Of-Care Assay – Cardiac Infarction – Product Status 21

Multianalyte 2-D Diffusion Point-Of-Care Assay – Cardiac Infarction – Product Description 21

Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview 22

Diagnostic Test – Cardiovascular Risk – Product Status 22

Diagnostic Test – Cardiovascular Risk – Product Description 22

Eachy Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Combination Kit – ACS – Product Status 23

Combination Kit – ACS – Product Description 23

Home Test Kit – ACS – Product Status 24

Home Test Kit – ACS – Product Description 24

Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Diagnostic Kit – Cardiovascular Diseases – Product Status 25

Diagnostic Kit – Cardiovascular Diseases – Product Description 25

MiCo BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

Labchip Based Test – Cardiac Marker – Product Status 26

Labchip Based Test – Cardiac Marker – Product Description 26

MyMD Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Diagnostic Test – Heart Attack – Product Status 27

Diagnostic Test – Heart Attack – Product Description 27

Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Omega-3 Cardiac Panel – Product Status 28

Omega-3 Cardiac Panel – Product Description 28

Nanospot.ai Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Cardiac Marker Antibody Test – Product Status 29

Cardiac Marker Antibody Test – Product Description 29

Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 30

Diagnostic Test – Cardiac Panel – Product Status 30

Diagnostic Test – Cardiac Panel – Product Description 30

Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 31

Portable POC System – CRP – Product Status 31

Portable POC System – CRP – Product Description 31

Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Point-Of-Care Platform – Cardiac Disorders Assay – Product Status 32

Point-Of-Care Platform – Cardiac Disorders Assay – Product Description 32

ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

Diagnostic Test – Heart Attack – Product Status 33

Diagnostic Test – Heart Attack – Product Description 33

True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 34

TrueDX – Cardiac Health Test – Product Status 34

TrueDX – Cardiac Health Test – Product Description 34

Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 35

GH Assay – Heart Failure – Product Status 35

GH Assay – Heart Failure – Product Description 35

IGFs Assay – Heart Failure – Product Status 36

IGFs Assay – Heart Failure – Product Description 36

NGAL-sp Test – Heart Failure – Product Status 36

NGAL-sp Test – Heart Failure – Product Description 37

TSH Assay – Heart Failure – Product Status 37

TSH Assay – Heart Failure – Product Description 37

Glossary 47

Figures

Cardiac Markers Rapid Tests & POC – Pipeline Products by Stage of Development 9

Cardiac Markers Rapid Tests & POC – Pipeline Products by Territory 10

Cardiac Markers Rapid Tests & POC – Pipeline Products by Regulatory Path 11

Cardiac Markers Rapid Tests & POC – Pipeline Products by Estimated Approval Date 12

Frequently asked questions

Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.